The European Society of Cardiology, through the European Heart Journal (Eur Heart J. 2010:31(3):379, Epub ahead of print January 4, 2010, doi: 10.1093/eurheartj/ehp593 and Eur Heart J. 2008;29(24):3069, Epub ahead of print November 24, 2008, doi: 10.1093/eurheartj/ ehn528), states that errors have been detected in their clinical practice guidelines and reports the following changes:

Clinical Practice Guidelines for preoperative cardiac risk assessment and perioperative cardiac management in noncardiac surgery

- The original version of this article contained an error on page 47e, in the footnote to Table 11. Where it states: eIn the presence of left ventricular (LV) dysfunction (ejection fraction >40%), it should read: eIn the presence of left ventricular (LV) dysfunction (ejection fraction ≤40%).

European Society of Cardiology (ESC) Clinical Practice Guidelines for the diagnosis and treatment of acute and chronic heart failure (2008)

- In Table 22, an asterisk (*) is missing after the diuretic indapamide and corresponds to the following text in the table footnote: "(*) indapamide is a non-thiazide sulfonamide."

- Table 28, in the line 'with alkalosis', the daily dose (mg) of the diuretic acetazolamide is erroneously given as 0.5 iv; the correct dose is 500 mg iv.

The authors apologize for failing to identify these errors earlier.